Psoriatic Arthritis
The role of dietary and lifestyle interventions in the management of rheumatic disease is poorly understood.
Treatment with ixekizumab led to rapid improvements in joint, skin, and nail symptoms for patients with psoriatic arthritis.
A study of real-world treatment and outcomes associated with ixekizumab found favorable efficacy in patients.
A study assessed deucravacitinib in patients with active psoriatic arthritis compared with placebo.
Patients with psoriatic arthritis who have enthesitis are more likely to persist on treatment with tofacitinib.
Treatment with guselkumab provided a durable therapeutic benefit to patients with psoriatic arthritis.
Advertisement
Expert Interviews on Psoriatic Arthritis
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.